study

Xinhua Silk Road: Think tank delegation tours JD.com global headquarters, experiencing its digital intelligence innovations

BEIJING, Nov. 21, 2025 /PRNewswire/ -- A think tank delegation comprising government representatives and industry experts from China and abroad…

2 months ago

IBM Study: Chief Data Officers Redefine Strategies as AI Ambitions Outpace Readiness

81% of Chief Data Officers surveyed prioritize investments that accelerate AI capabilities and initiatives. 78% of surveyed leaders cite leveraging…

2 months ago

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…

2 months ago

Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel

Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health and Multiomics Research MORRISVILLE, N.C., Nov. 4, 2025…

2 months ago

DXC Named a Leader in ISG Provider Lens AWS Ecosystem Partners Study

DXC receives 16 awards globally from ISG's assessment of AWS partners ASHBURN, Va. , Nov. 5, 2025 /PRNewswire/ -- DXC Technology…

2 months ago

Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa

DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…

2 months ago

Descartes Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth

Automation and AI emerge as critical differentiators for logistics services providers facing global instability, tariff volatility and cost pressures LONDON…

2 months ago

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

2 months ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

2 months ago

Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study

- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications - BASEL,…

2 months ago